Krebs Biochem reports mixed financial results for Q4 2023, with positive sales growth but increased interest expenses

Feb 12 2024 04:25 PM IST
share
Share Via
Krebs Biochemicals & Industries, a microcap pharmaceutical company, has reported a flat performance in the quarter ending December 2023, with a score of 0 compared to -6 in the previous quarter. However, net sales have shown a strong growth of 42.79%, while interest expenses have also increased by 28.09%. Investors should carefully evaluate these factors before investing.

Krebs Biochemicals & Industries, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending December 2023. The company's stock has been given a 'Sell' call by MarketsMOJO.

According to the financial report, Krebs Biochem has shown a flat performance in the quarter, with a score of 0 compared to -6 in the previous quarter. However, there are some positive aspects to the company's financials.

One of the highlights is the growth in net sales, which has increased by 42.79% year on year, reaching Rs 12.98 crore. This indicates a strong sales trend in the near term for the company.

On the other hand, the company's interest expenses have also increased by 28.09% over the preceding nine months period, reaching Rs 3.42 crore. This could be a cause for concern as it signifies increased borrowings for the company.

Overall, Krebs Biochem's financial performance for the quarter ending December 2023 has been mixed, with some positive and negative aspects. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News